Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Diagnostics & Demographics: Is Your Lab Prepared to Accommodate an Aging Population?
From - National Intelligence Report
Talk of an aging population isn't idle chatter. According to the U.S. Census Bureau, 2030 will mark a significant turning point in…
Evidence Suggests Need for Expanded HCV Testing, Particularly Coupled With Opioid Screening in Young People
From - Diagnostic Testing & Emerging Technologies
Current hepatitis C virus (HCV) screening strategies may not be adequate in the face of the opioid epidemic…
Medicare Reimbursement: Part B Lab Payments in Final Year before PAMA
From - Laboratory Industry Report
Part B payments for lab tests in 2017, the final year under the old reimbursement rules, totaled $7.1 billion, up slightly from…
Labs Need to Prepare for Upcoming PAMA Data Collection Period
From - National Intelligence Report
The impact of PAMA (the Protecting Access to Medicare Act) is already being felt in the laboratory industry…
Lab Leaders Have New Opportunities in the Age of Consumerism
From - Laboratory Industry Report
The G2 Power Panel provided attendees at the 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) an opportunity to learn how some of…
Attendees Given Insider’s Look at a Hospital Laboratory Joint Venture
From - G2 Compliance Advisor
Hospital systems are increasingly exploring joint ventures as a means to monetize some of the hospital outreach laboratory's assets without…
Lab 2.0, The Future of Labs
From - Diagnostic Testing & Emerging Technologies
What will the laboratory of the future look like?
Attendees at G2's 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) got a glimpse in the keynote…